Vivos (RDGL) Gross Profit Growth (3y) (2013 - 2025)
Vivos (RDGL) Gross Profit Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 9.77% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 12.24% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 14.82% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 9.36% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 14.95% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 3.96% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.99% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 8.95% |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | 9.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.77% |
| Sep 30, 2025 | -25.17% |
| Jun 30, 2025 | -82.69% |
| Mar 31, 2025 | -42.74% |
| Dec 31, 2024 | 4.14% |
| Sep 30, 2024 | -50.45% |
| Dec 31, 2015 | -97.31% |
| Sep 30, 2015 | -34.53% |
| Jun 30, 2015 | -26.03% |
| Mar 31, 2015 | -38.08% |
| Dec 31, 2014 | -33.44% |
| Sep 30, 2014 | -26.14% |
| Jun 30, 2014 | -57.66% |
| Mar 31, 2014 | -52.09% |
| Dec 31, 2013 | -26.05% |
| Sep 30, 2013 | -42.50% |